A detailed history of Manufacturers Life Insurance Company, The transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 13,480 shares of URGN stock, worth $160,546. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,480
Previous 13,302 1.34%
Holding current value
$160,546
Previous $223,000 23.32%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$12.7 - $17.92 $2,260 - $3,189
178 Added 1.34%
13,480 $171,000
Q2 2024

Aug 14, 2024

SELL
$12.72 - $19.2 $244,465 - $369,004
-19,219 Reduced 59.1%
13,302 $223,000
Q1 2024

May 14, 2024

BUY
$13.81 - $19.33 $301,127 - $421,490
21,805 Added 203.48%
32,521 $487,000
Q4 2023

Feb 13, 2024

BUY
$10.87 - $15.93 $116,482 - $170,705
10,716 New
10,716 $160,000
Q1 2022

May 20, 2022

SELL
$5.92 - $9.73 $70,590 - $116,020
-11,924 Closed
0 $0
Q4 2021

Feb 16, 2022

SELL
$9.03 - $19.13 $2,979 - $6,312
-330 Reduced 2.69%
11,924 $113,000
Q3 2021

Nov 12, 2021

SELL
$14.31 - $18.39 $9,501 - $12,210
-664 Reduced 5.14%
12,254 $206,000
Q2 2021

Aug 12, 2021

BUY
$15.2 - $20.94 $8,147 - $11,223
536 Added 4.33%
12,918 $197,000
Q1 2021

May 03, 2021

SELL
$17.99 - $26.96 $2,104 - $3,154
-117 Reduced 0.94%
12,382 $241,000
Q4 2020

Feb 12, 2021

BUY
$17.54 - $25.43 $10,155 - $14,723
579 Added 4.86%
12,499 $225,000
Q2 2020

Aug 10, 2020

SELL
$16.5 - $29.7 $6,682 - $12,028
-405 Reduced 3.29%
11,920 $303,000
Q1 2020

May 15, 2020

BUY
$13.68 - $34.6 $7,428 - $18,787
543 Added 4.61%
12,325 $220,000
Q4 2019

Feb 14, 2020

SELL
$21.11 - $34.86 $8,042 - $13,281
-381 Reduced 3.13%
11,782 $352,000
Q3 2019

Nov 12, 2019

BUY
$23.83 - $36.44 $13,368 - $20,442
561 Added 4.84%
12,163 $292,000
Q2 2019

Aug 14, 2019

BUY
$32.75 - $40.35 $379,965 - $468,140
11,602 New
11,602 $417,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $271M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.